Copyright Reports & Markets. All rights reserved.

Global PD-L1 Biomarker Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 PD-L1 IHC 22C3 Assay
    • 1.4.3 PD-L1 IHC 28-8 Assay
    • 1.4.4 PD-L1 (SP142) Assay
    • 1.4.5 PD-L1 (SP263) Assay
  • 1.5 Market by Application
    • 1.5.1 Global PD-L1 Biomarker Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Diagnostic Center
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 PD-L1 Biomarker Testing Market Perspective (2015-2026)
  • 2.2 PD-L1 Biomarker Testing Growth Trends by Regions
    • 2.2.1 PD-L1 Biomarker Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 PD-L1 Biomarker Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 PD-L1 Biomarker Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key PD-L1 Biomarker Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top PD-L1 Biomarker Testing Players by Market Size
    • 3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2015-2020)
    • 3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global PD-L1 Biomarker Testing Market Concentration Ratio
    • 3.2.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2019
  • 3.3 PD-L1 Biomarker Testing Key Players Head office and Area Served
  • 3.4 Key Players PD-L1 Biomarker Testing Product Solution and Service
  • 3.5 Date of Enter into PD-L1 Biomarker Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2021-2026)

5 PD-L1 Biomarker Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global PD-L1 Biomarker Testing Market Size by Application (2015-2020)
  • 5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America PD-L1 Biomarker Testing Market Size (2015-2020)
  • 6.2 PD-L1 Biomarker Testing Key Players in North America (2019-2020)
  • 6.3 North America PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 6.4 North America PD-L1 Biomarker Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe PD-L1 Biomarker Testing Market Size (2015-2020)
  • 7.2 PD-L1 Biomarker Testing Key Players in Europe (2019-2020)
  • 7.3 Europe PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 7.4 Europe PD-L1 Biomarker Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China PD-L1 Biomarker Testing Market Size (2015-2020)
  • 8.2 PD-L1 Biomarker Testing Key Players in China (2019-2020)
  • 8.3 China PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 8.4 China PD-L1 Biomarker Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan PD-L1 Biomarker Testing Market Size (2015-2020)
  • 9.2 PD-L1 Biomarker Testing Key Players in Japan (2019-2020)
  • 9.3 Japan PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 9.4 Japan PD-L1 Biomarker Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia PD-L1 Biomarker Testing Market Size (2015-2020)
  • 10.2 PD-L1 Biomarker Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia PD-L1 Biomarker Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India PD-L1 Biomarker Testing Market Size (2015-2020)
  • 11.2 PD-L1 Biomarker Testing Key Players in India (2019-2020)
  • 11.3 India PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 11.4 India PD-L1 Biomarker Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America PD-L1 Biomarker Testing Market Size (2015-2020)
  • 12.2 PD-L1 Biomarker Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America PD-L1 Biomarker Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America PD-L1 Biomarker Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Agilent Technologies
    • 13.1.1 Agilent Technologies Company Details
    • 13.1.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
    • 13.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2015-2020))
    • 13.1.5 Agilent Technologies Recent Development
  • 13.2 Eli Lilly
    • 13.2.1 Eli Lilly Company Details
    • 13.2.2 Eli Lilly Business Overview and Its Total Revenue
    • 13.2.3 Eli Lilly PD-L1 Biomarker Testing Introduction
    • 13.2.4 Eli Lilly Revenue in PD-L1 Biomarker Testing Business (2015-2020)
    • 13.2.5 Eli Lilly Recent Development
  • 13.3 AstraZeneca
    • 13.3.1 AstraZeneca Company Details
    • 13.3.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.3.3 AstraZeneca PD-L1 Biomarker Testing Introduction
    • 13.3.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2015-2020)
    • 13.3.5 AstraZeneca Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche PD-L1 Biomarker Testing Introduction
    • 13.4.4 Roche Revenue in PD-L1 Biomarker Testing Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Bristol-Myers Squibb
    • 13.5.1 Bristol-Myers Squibb Company Details
    • 13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 13.5.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction
    • 13.5.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2015-2020)
    • 13.5.5 Bristol-Myers Squibb Recent Development
  • 13.6 Merck
    • 13.6.1 Merck Company Details
    • 13.6.2 Merck Business Overview and Its Total Revenue
    • 13.6.3 Merck PD-L1 Biomarker Testing Introduction
    • 13.6.4 Merck Revenue in PD-L1 Biomarker Testing Business (2015-2020)
    • 13.6.5 Merck Recent Development
  • 13.7 Pfizer
    • 13.7.1 Pfizer Company Details
    • 13.7.2 Pfizer Business Overview and Its Total Revenue
    • 13.7.3 Pfizer PD-L1 Biomarker Testing Introduction
    • 13.7.4 Pfizer Revenue in PD-L1 Biomarker Testing Business (2015-2020)
    • 13.7.5 Pfizer Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global PD-L1 Biomarker Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the PD-L1 Biomarker Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Agilent Technologies
    Eli Lilly
    AstraZeneca
    Roche
    Bristol-Myers Squibb
    Merck
    Pfizer
    ...

    Market segment by Type, the product can be split into
    PD-L1 IHC 22C3 Assay
    PD-L1 IHC 28-8 Assay
    PD-L1 (SP142) Assay
    PD-L1 (SP263) Assay
    Market segment by Application, split into
    Hospital
    Diagnostic Center
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global PD-L1 Biomarker Testing status, future forecast, growth opportunity, key market and key players.
    To present the PD-L1 Biomarker Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of PD-L1 Biomarker Testing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now